The MV Hondius set sail from Ushuaia on April 1, marketed as a high‑end wildlife cruise costing roughly $8,000‑$27,000 per passenger. Within two weeks a passenger died, and health officials later linked three deaths to Andes hantavirus, a rodent‑borne disease. Media outlets followed the saga, and the cruise line’s reputation suffered as bookings for similar wildlife tours dipped in subsequent weeks.

Passengers from 23 nations were locked in cabins while crews traced contacts and decontaminated the ship. The World Health Organization logged ten cases—eight confirmed, two suspected—and linked two deaths to hantavirus. Tenerife authorities imposed strict quarantine on docking, and U.S. health officials isolated 18 former passengers, monitoring 23 additional contacts.

The incident exposes vulnerabilities in premium expedition travel, where remote ports and small groups strain biosecurity. Operators like Oceanwide Expeditions now face heightened scrutiny and potential liability, while insurers reassess disease‑related premiums. Share prices of listed cruise operators fell modestly as analysts warned of tighter health regulations.